Found 9 matching trials
A Study of Lasmiditan in Healthy Japanese and Caucasian Participants
PHASE1The main purpose of this study is to evaluate the safety and tolerability o...
A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine
PHASE2This study will assess the efficacy and safety of lasmiditan in the acute t...
Location
Takanoko Hospital
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
PHASE3The reason for this study is to see how effective and safe the study drug k...
Location
Rehabilitation & Neurological Services LLC
Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment
PHASE2The purpose of this study is to evaluate the efficacy and safety of a range...
Location
Multiple Locations
A Study of Lasmiditan in Healthy Chinese Participants
PHASE1This is a study of lasmiditan in healthy Chinese participants. The purposes...
Location
HuaShan Hospital Affiliated To Fudan University
Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine
PHASE3This is a prospective randomized, double-blind, placebo-controlled study in...
Location
Alabama Clinical Therapeutics, LLC
A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants
PHASE1The purpose of this study is to evaluate the effect of lasmiditan on simula...
Location
Covance Clinical Research Inc
Ditan Acute tReatments: Effectiveness and Tolerability (DART)
N/AThe purpose of this prospective and multicentric study is to evaluate the e...
Location
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
PHASE3The reason for this 12-month, open-label study is to see if the study drug ...
Location
Central Research Associates